NCT00626093View on ClinicalTrials.gov

'Effect of CRT on Defibrillation Threshold Estimates' Study

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Sudden Cardiac Death
Interventions
DEVICE

Cardiac Resynchronization Therapy - Defibrillator (CRT-D)

"* Patients in the study who receive Cardiac Resynchronization Therapy - Defibrillator (CRT-D) are indicated for Cardiac Resynchronization Therapy (CRT).~* Patient undergoes Defibrillation threshold (DFT) testing at implant and at 6 months. Defibrillation threshold (DFT) testing will include 3 ventricular fibrillation (VF) inductions."

Trial Locations (2)

80907

Penrose Hospital, Colorado Springs

90404

Pacific Heart Institute, Santa Monica

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY